Provost Miriam
- SEC CIK
- 0001773663
No open-market purchases or sales filed in the past year.
Current role at each company
- TMDX TransMedics Group, Inc.VP, Global Regulatory Affairsas of Dec 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Provost Miriam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 (view filing) | Dec 13 | 2 days | Provost MiriamVP, Global Regulatory Affairs | SSale | −4.12K | $75.10 | −$309.6K | −14.1%25.1K after | 3 lots |
| Sep 5, 2023 (view filing) | Aug 31 | 5 days | Provost MiriamVP, Global Regulatory Affairs | SSale | −2.71K | $66.52 | −$180.1K | −10.3%23.6K after | |
| Dec 15, 2022 (view filing) | Dec 13 | 2 days | Provost MiriamVP, Global Regulatory Affairs | SSale | −4.32K | $62.53 | −$269.8K | −22.2%15.2K after | 2 lots |
| Dec 13, 2022 (view filing) | Dec 9 | 4 days | Provost MiriamVP, Global Regulatory Affairs | SSale | −3.61K | $59.00 | −$213.2K | −21.0%13.6K after | 2 lots |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Provost MiriamVP of US Regulatory & FDA Rel. | SSale | −3.88K | $31.34 | −$121.5K | −31.2%8.55K after |